COVID Vaccine Hopeful Lands $100M In Funding Round
Coronavirus vaccine developer Icosavax, working with Latham & Watkins LLP, said Wednesday that it's been injected with $100 million in a funding round led by health care and life sciences investor...To view the full article, register now.
Already a subscriber? Click here to view full article